Filter
483
Text search:
The
Cochrane
HIV
Featured
67
88
Language
Document type
258
95
72
23
16
10
6
2
1
Countries / Regions
19
19
13
11
10
8
8
8
7
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
104
99
73
27
13
8
7
Toolboxes
86
46
38
36
30
15
13
13
10
7
6
5
5
5
4
4
3
3
3
2
1
1
1
1
1
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
Цель настоящего доклада — повысить осведомленность о деменции как
одной из приоритетных проблем общественного здравоохранения, сформу-
лировать подход к этой п
...
EMCDDA Insights - 11
Accessed: 14.03.2019
Miscellaneous
Chapter J.2
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
Development assistance for health (DAH)
plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically
focused on infectious diseases and maternal and child
health, there is a lack of comprehensive analysis of DAH
trends, strategic shifts and the
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Key populations brief.
Краткое руководство
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
Lancet 2018; 391: 700–08
Perspectives on Drugs
Accessed Febr. 6, 2020
Updated May 2021
